Navigation Links
Octopus3 Tissue Stabilizer (malleable pods)

ProductsOctopus3 Tissue Stabilizer (malleable pods)
Company Medtronic Inc.
Item Octopus3 Tissue Stabilizer (malleable pods)
Features 
  • Malleable stabilizer pods that can be formed to the unique contours of the patient's anatomy.
  • A unique tissue-spreading mechanism enhances stabilization of the anastomotic site and presentation of the cornonary.
  • Description Part of the Octopus System which includes both the Starfish & Octopus3. The Octopus3 Tissue Stabilizer is the pioneering and market-leading suction device.
    Info Medtronic Inc.
    Customer Service: (800) 551-5544
    Web site: http://www.medtronic.com/

    Related medicine products :

    1. Straight Tissue Forceps
    2. Bishop-Harmon Straight Tissue Forceps
    3. Bishop-Harmon Curved Tissue Forceps
    4. Straight Tissue Forceps - Non-Magnetic
    5. Programmable Tissue Stainer TST 40, 115V, 60Hz, 100VA
    6. Programmable Tissue Stainer TST 40, 230V, 50Hz, 100VA
    7. Tissue-Tek DRS 2000
    8. Micro Tissue Forceps
    9. Micro Tissue Forceps with round handle
    10. LICOX Brain Tissue Oxygen Monitoring System
    11. Tissue Forceps (Bishop-Harmon)
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products:
    (Date:3/23/2017)... Yardley, PA (PRWEB) , ... March 23, 2017 ... ... received Patient Oriented Disease Management Accreditation from the NCQA. The accreditation covers StayWell’s ... programs. , Accredited status is granted to organizations that have excellent programs ...
    (Date:3/23/2017)... ... , ... The TouchPoint Solution, home of Buzzies *, is boosting the ... , “Buzzies change the way we interact with stress and live our day-to-day lives,” ... date in December 2016, The TouchPoint Solution has sold more than $750,000 in product ...
    (Date:3/23/2017)... , ... March 23, 2017 , ... After raising more ... FaceCradle , the most-funded travel pillow in crowdfunding history, has established a ... its wildly popular travel innovation to Americans. , “We’re excited to be operating on ...
    (Date:3/23/2017)... ... March 23, 2017 , ... ... today announced rapid completion of the strategic executive team expansion needed to further ... to the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. ...
    (Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
    Breaking Medicine News(10 mins):
    (Date:3/23/2017)... MUMBAI , March 23, 2017 ... de Piramal Enterprises Limited, anuncia el nombramiento de ... PPS ofrece una plataforma de servicios integrados completa ... Needleman desempeñará un cargo clave en el crecimiento ... comercial, Needleman será responsable de impulsar todas las ...
    (Date:3/23/2017)... 23, 2017  Galmed Pharmaceuticals Ltd. (Nasdaq: ... clinical-stage biopharmaceutical company focused on the development of ... nonalcoholic steatohepatitis, or NASH, and other liver diseases, ... twelve months ended December 31, 2016, and announced new ... demonstrating Aramchol™,s potential direct effect on liver fibrosis. ...
    (Date:3/23/2017)... 23, 2017 ReNeuron reported in December ... in chronic stroke patients, despite not meeting the three-month time ... the Action Research Arm Test (ARAT). As a result, the ... controlled clinical study in 2017. Beyond CTX, we expect safety ... 2017 and Phase I data from its critical limb ischaemia ...
    Breaking Medicine Technology: